- Home
- SNX vs ITCI Comparison
SNX vs ITCI Comparison
Compare SNX & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- ITCI
- Stock Information
- Founded
- SNX 1980
- ITCI 2002
- Country
- SNX United States
- ITCI United States
- Employees
- SNX N/A
- ITCI N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- SNX Technology
- ITCI Health Care
- Exchange
- SNX Nasdaq
- ITCI Nasdaq
- Market Cap
- SNX 9.5B
- ITCI 8.0B
- IPO Year
- SNX 2003
- ITCI N/A
- Fundamental
- Price
- SNX $121.30
- ITCI $85.45
- Analyst Decision
- SNX Buy
- ITCI Strong Buy
- Analyst Count
- SNX 8
- ITCI 12
- Target Price
- SNX $134.75
- ITCI $97.67
- AVG Volume (30 Days)
- SNX 519.9K
- ITCI 560.2K
- Earning Date
- SNX 01-07-2025
- ITCI 10-30-2024
- Dividend Yield
- SNX 1.32%
- ITCI N/A
- EPS Growth
- SNX 10.98
- ITCI N/A
- EPS
- SNX 7.74
- ITCI N/A
- Revenue
- SNX $57,015,179,000.00
- ITCI $613,728,000.00
- Revenue This Year
- SNX $1.55
- ITCI $48.26
- Revenue Next Year
- SNX $5.70
- ITCI $38.45
- P/E Ratio
- SNX $15.76
- ITCI N/A
- Revenue Growth
- SNX N/A
- ITCI 46.08
- 52 Week Low
- SNX $96.93
- ITCI $58.93
- 52 Week High
- SNX $133.85
- ITCI $93.45
- Technical
- Relative Strength Index (RSI)
- SNX 56.22
- ITCI 53.68
- Support Level
- SNX $118.18
- ITCI $84.63
- Resistance Level
- SNX $122.24
- ITCI $86.99
- Average True Range (ATR)
- SNX 1.99
- ITCI 2.08
- MACD
- SNX 0.43
- ITCI -0.47
- Stochastic Oscillator
- SNX 89.89
- ITCI 46.28
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and datacenter infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include, the Americas, Europe, and APJ.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.